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In the recent article by N. Topley et a!, Kidney mt 36:
609—616, 1989, an error appeared in the first sentence of the
abstract. The word, independent, should read dependent. The
abstract is reprinted in its corrected entirety below.
Type 1 fimbrlate strains of escherichia coli initiate renal parenchymal
scarring. The renal scarring which characterizes chronic pyelonephritis
is initiated by bacterial infection and is dependent on the activation of
an inflammatory response. Although the presence of polymorphonu-
clear leukocytes (PMN) is essential for initiating the scarring process,
the bacterial structures responsible for their activation have not been
investigated. In an animal model of chronic pyelonephritis the surface
area of the renal scars produced by Type I fimbriate escherichia coil (E.
coli) was significantly greater than that of those produced by P fimbriate
and non-fimbriate strains (P < 0.01). The activation of human PMN by
the same Type 1 fimbriate organisms resulted in a significant release of
lysosomal neutral protease activity (P < 0.001) and activation of the
respiratory burst (P < 0.01). The neutral protease release in response to
P fimbriate and non-fimbriate organisms was not significantly increased.
The extent of renal scarring also correlated with the release of neutral
protease activity (P < 0.02) and with the degree of activation of the
respiratory burst (P < 0.05). These results demonstrate that the ability
of E. coli strains to cause renal scars may be related to their capacity to
express Type 1 fimbria, which may be a causative factor in the in vivo
activation of the inflammatory response.
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